How participants in cancer trials are chosen: ethics and conflicting interests.
AffiliationCancer Research UK, University of Manchester, Department of Medical Oncology, Christie Hospital, Withington, Manchester M20 4BX, UK. Gordon.Jayson@christie-tr.nwest.nhs.uk
MetadataShow full item record
AbstractThe development of new drugs for cancer is extremely complex and expensive, and poses ethical problems. In this article we will review issues in clinical trials for cancer drugs that will cast new light on the doctor-patient relationship and their interaction with industry, the health service, academic and administrative organizations. We show that the Declaration of Helsinki cannot be applied to cancer trials as it is currently written, that patients do not and perhaps cannot give fully informed consent to participate, and that the results of clinical trials do not translate into daily practice in a way that patients might expect.
CitationHow participants in cancer trials are chosen: ethics and conflicting interests. 2006, 6 (4):330-6 Nat. Rev. Cancer
JournalNature Reviews. Cancer
- Referral of patients with cancer for participation in randomized clinical trials: ethical considerations.
- Authors: Levine RJ
- Issue date: 1986 Mar-Apr
- American Society of Clinical Oncology policy statement: oversight of clinical research.
- Authors: American Society of Clinical Oncology.
- Issue date: 2003 Jun 15
- Breast cancer trials on trial. A case of conflicting ethical interests.
- Authors: Mueller CB
- Issue date: 1995 May 15
- The 2008 Declaration of Helsinki: some reflections.
- Authors: Giordano S
- Issue date: 2010 Oct
- Patient perspectives on physician conflict of interest in industry-sponsored clinical trials for multiple sclerosis therapeutics.
- Authors: Solomon AJ, Klein EP, Corboy JR, Bernat JL
- Issue date: 2015 Oct